Antiarrhythmic drugs are used commonly in out-of-hospital cardiac arrest for shock-refractory ventricular fibrillation or pulseless ventricular tachycardia, but without proven survival benefit. In ...
January 21, 2005 — In mid-January, the US Food and Drug Administration (FDA) and Wyeth Pharmaceuticals sent out "Dear Doctor" and "Dear Pharmacist" letters notifying recipients that a new medication ...
Amiodarone HCl 50mg/mL; soln for IV infusion after dilution; contains polysorbate 80. Amiodarone, a class III antiarrhythmic, possesses electrophysiologic characteristics of all four Vaughan Williams ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results